(Q33181807)

English

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

anti-retroviral agent

0 references

cerebrospinal fluid

0 references

author name string

Enting RH

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Prins JM

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Jurriaans S

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Brinkman K

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Portegies P

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Lange JM

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

language of work or name

0 references

publication date

15 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1095-1099

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.

1 reference

https://api.crossref.org/works/10.1086%2F319602

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33181807&oldid=1962821828"